BrightSpring Health Services, Inc. Common Stock (BTSG)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $14.17B
Last updated: Nov 17, 2026 at 11:05 AM ET
BrightSpring Health Services, Inc. Common Stock (BTSG) P/E Ratio & Valuation Multiples
BrightSpring Health Services, Inc. Common Stock (BTSG) trades at 41.7x trailing earnings and 1.0x sales. Its forward P/E is 23.1x. The median P/E across 8 similar companies is 32.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 80.5% higher over the next year. Its free cash flow yield is 3.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 41.7x |
| Forward P/E | 23.1x |
| Price to sales | 1.0x |
| Price to book | 6.8x |
| EV/EBITDA | 23.7x |
| Price to FCF | 30.0x |
|---|---|
| EV/FCF | 33.3x |
| PEG | N/A |
| FCF yield | 3.3% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BTSG
What is BTSG's forward P/E ratio?
BrightSpring Health Services, Inc. Common Stock has a forward P/E ratio of 23.1x.
Is BTSG stock overvalued?
GNG's valuation label for BTSG is Overvalued. Its P/E of 41.7x compares with a median of 32.8x across 8 similar companies.
What is BTSG's price to sales ratio?
BrightSpring Health Services, Inc. Common Stock has a price to sales ratio of 1.0x.
BTSG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors